Wearable Neuromodulation Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Table of Contents

1 Market Overview
    1.1 Wearable Neuromodulation Device Product Introduction
    1.2 Global Wearable Neuromodulation Device Market Size Forecast
        1.2.1 Global Wearable Neuromodulation Device Sales Value (2021–2032)
        1.2.2 Global Wearable Neuromodulation Device Sales Volume (2021–2032)
        1.2.3 Global Wearable Neuromodulation Device Sales Price (2021–2032)
    1.3 Wearable Neuromodulation Device Market Trends & Drivers
        1.3.1 Wearable Neuromodulation Device Industry Trends
        1.3.2 Wearable Neuromodulation Device Market Drivers & Opportunities
        1.3.3 Wearable Neuromodulation Device Market Challenges
        1.3.4 Wearable Neuromodulation Device Market Restraints
        1.3.5 Impact of U.S. Tariffs
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Wearable Neuromodulation Device Players Revenue Ranking (2025)
    2.2 Global Wearable Neuromodulation Device Revenue by Company (2021–2026)
    2.3 Global Wearable Neuromodulation Device Sales Volume Ranking of Players (2025)
    2.4 Global Wearable Neuromodulation Device Sales Volume by Company (2021–2026)
    2.5 Global Wearable Neuromodulation Device Average Price by Company (2021–2026)
    2.6 Key Manufacturers Wearable Neuromodulation Device Manufacturing Base and Headquarters
    2.7 Key Manufacturers Wearable Neuromodulation Device Product Offerings
    2.8 Key Manufacturers Start of Mass Production of Wearable Neuromodulation Device
    2.9 Wearable Neuromodulation Device Market Competitive Analysis
        2.9.1 Wearable Neuromodulation Device Market Concentration Rate (2021–2026)
        2.9.2 Global 5 and 10 Largest Manufacturers by Wearable Neuromodulation Device Revenue in 2025
        2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Wearable Neuromodulation Device revenue, 2025
    2.10 Mergers & Acquisitions and Expansion

3 Segmentation Wearable Neuromodulation Device Market Classification
    3.1 Introduction by Type
        3.1.1 Head Mounted
        3.1.2 Hand-worn
        3.1.3 Leg-worn
        3.1.4 Foot-worn
        3.1.5 Global Wearable Neuromodulation Device Sales Value by Type
            3.1.5.1 Global Wearable Neuromodulation Device Sales Value by Type (2021 vs 2025 vs 2032)
            3.1.5.2 Global Wearable Neuromodulation Device Sales Value, by Type (2021–2032)
            3.1.5.3 Global Wearable Neuromodulation Device Sales Value, by Type (%), 2021–2032
        3.1.6 Global Wearable Neuromodulation Device Sales Volume by Type
            3.1.6.1 Global Wearable Neuromodulation Device Sales Volume by Type (2021 vs 2025 vs 2032)
            3.1.6.2 Global Wearable Neuromodulation Device Sales Volume, by Type (2021–2032)
            3.1.6.3 Global Wearable Neuromodulation Device Sales Volume, by Type (%), 2021–2032
        3.1.7 Global Wearable Neuromodulation Device Average Price by Type (2021–2032)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinic
        4.1.3 Residential
        4.1.4 Nursing Home
        4.1.5 Others
    4.2 Global Wearable Neuromodulation Device Sales Value by Application
        4.2.1 Global Wearable Neuromodulation Device Sales Value by Application (2021 vs 2025 vs 2032)
        4.2.2 Global Wearable Neuromodulation Device Sales Value, by Application (2021–2032)
        4.2.3 Global Wearable Neuromodulation Device Sales Value, by Application (%), 2021–2032
    4.3 Global Wearable Neuromodulation Device Sales Volume by Application
        4.3.1 Global Wearable Neuromodulation Device Sales Volume by Application (2021 vs 2025 vs 2032)
        4.3.2 Global Wearable Neuromodulation Device Sales Volume, by Application (2021–2032)
        4.3.3 Global Wearable Neuromodulation Device Sales Volume, by Application (%), 2021–2032
    4.4 Global Wearable Neuromodulation Device Average Price by Application (2021–2032)

5 Segmentation by Region
    5.1 Global Wearable Neuromodulation Device Sales Value by Region
        5.1.1 Global Wearable Neuromodulation Device Sales Value by Region: 2021 vs 2025 vs 2032
        5.1.2 Global Wearable Neuromodulation Device Sales Value by Region (2021–2026)
        5.1.3 Global Wearable Neuromodulation Device Sales Value by Region (2027–2032)
        5.1.4 Global Wearable Neuromodulation Device Sales Value by Region (%), 2021–2032
    5.2 Global Wearable Neuromodulation Device Sales Volume by Region
        5.2.1 Global Wearable Neuromodulation Device Sales Volume by Region: 2021 vs 2025 vs 2032
        5.2.2 Global Wearable Neuromodulation Device Sales Volume by Region (2021–2026)
        5.2.3 Global Wearable Neuromodulation Device Sales Volume by Region (2027–2032)
        5.2.4 Global Wearable Neuromodulation Device Sales Volume by Region (%), 2021–2032
    5.3 Global Wearable Neuromodulation Device Average Price by Region (2021–2032)
    5.4 North America
        5.4.1 North America Wearable Neuromodulation Device Sales Value, 2021–2032
        5.4.2 North America Wearable Neuromodulation Device Sales Value by Country (%), 2025 vs 2032
    5.5 Europe
        5.5.1 Europe Wearable Neuromodulation Device Sales Value, 2021–2032
        5.5.2 Europe Wearable Neuromodulation Device Sales Value by Country (%), 2025 vs 2032
    5.6 Asia Pacific
        5.6.1 Asia Pacific Wearable Neuromodulation Device Sales Value, 2021–2032
        5.6.2 Asia Pacific Wearable Neuromodulation Device Sales Value by Region (%), 2025 vs 2032
    5.7 South America
        5.7.1 South America Wearable Neuromodulation Device Sales Value, 2021–2032
        5.7.2 South America Wearable Neuromodulation Device Sales Value by Country (%), 2025 vs 2032
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Wearable Neuromodulation Device Sales Value, 2021–2032
        5.8.2 Middle East & Africa Wearable Neuromodulation Device Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Wearable Neuromodulation Device Sales Value Growth Trends, 2021 vs 2025 vs 2032
    6.2 Key Countries/Regions Wearable Neuromodulation Device Sales Value and Sales Volume
        6.2.1 Key Countries/Regions Wearable Neuromodulation Device Sales Value, 2021–2032
        6.2.2 Key Countries/Regions Wearable Neuromodulation Device Sales Volume, 2021–2032
    6.3 United States
        6.3.1 United States Wearable Neuromodulation Device Sales Value, 2021–2032
        6.3.2 United States Wearable Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
        6.3.3 United States Wearable Neuromodulation Device Sales Value by Application, 2025 vs 2032
    6.4 Europe
        6.4.1 Europe Wearable Neuromodulation Device Sales Value, 2021–2032
        6.4.2 Europe Wearable Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
        6.4.3 Europe Wearable Neuromodulation Device Sales Value by Application, 2025 vs 2032
    6.5 China
        6.5.1 China Wearable Neuromodulation Device Sales Value, 2021–2032
        6.5.2 China Wearable Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
        6.5.3 China Wearable Neuromodulation Device Sales Value by Application, 2025 vs 2032
    6.6 Japan
        6.6.1 Japan Wearable Neuromodulation Device Sales Value, 2021–2032
        6.6.2 Japan Wearable Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
        6.6.3 Japan Wearable Neuromodulation Device Sales Value by Application, 2025 vs 2032
    6.7 South Korea
        6.7.1 South Korea Wearable Neuromodulation Device Sales Value, 2021–2032
        6.7.2 South Korea Wearable Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
        6.7.3 South Korea Wearable Neuromodulation Device Sales Value by Application, 2025 vs 2032
    6.8 Southeast Asia
        6.8.1 Southeast Asia Wearable Neuromodulation Device Sales Value, 2021–2032
        6.8.2 Southeast Asia Wearable Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
        6.8.3 Southeast Asia Wearable Neuromodulation Device Sales Value by Application, 2025 vs 2032
    6.9 India
        6.9.1 India Wearable Neuromodulation Device Sales Value, 2021–2032
        6.9.2 India Wearable Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
        6.9.3 India Wearable Neuromodulation Device Sales Value by Application, 2025 vs 2032

7 Company Profiles
    7.1 Nexalin
        7.1.1 Nexalin Company Information
        7.1.2 Nexalin Introduction and Business Overview
        7.1.3 Nexalin Wearable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
        7.1.4 Nexalin Wearable Neuromodulation Device Product Offerings
        7.1.5 Nexalin Recent Developments
    7.2 Cefaly
        7.2.1 Cefaly Company Information
        7.2.2 Cefaly Introduction and Business Overview
        7.2.3 Cefaly Wearable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
        7.2.4 Cefaly Wearable Neuromodulation Device Product Offerings
        7.2.5 Cefaly Recent Developments
    7.3 ​Theranica Bio-Electronics Ltd.
        7.3.1 ​Theranica Bio-Electronics Ltd. Company Information
        7.3.2 ​Theranica Bio-Electronics Ltd. Introduction and Business Overview
        7.3.3 ​Theranica Bio-Electronics Ltd. Wearable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
        7.3.4 ​Theranica Bio-Electronics Ltd. Wearable Neuromodulation Device Product Offerings
        7.3.5 ​Theranica Bio-Electronics Ltd. Recent Developments
    7.4 Neurolief Inc.
        7.4.1 Neurolief Inc. Company Information
        7.4.2 Neurolief Inc. Introduction and Business Overview
        7.4.3 Neurolief Inc. Wearable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
        7.4.4 Neurolief Inc. Wearable Neuromodulation Device Product Offerings
        7.4.5 Neurolief Inc. Recent Developments
    7.5 eNeura Inc.
        7.5.1 eNeura Inc. Company Information
        7.5.2 eNeura Inc. Introduction and Business Overview
        7.5.3 eNeura Inc. Wearable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
        7.5.4 eNeura Inc. Wearable Neuromodulation Device Product Offerings
        7.5.5 eNeura Inc. Recent Developments
    7.6 Avation Medical
        7.6.1 Avation Medical Company Information
        7.6.2 Avation Medical Introduction and Business Overview
        7.6.3 Avation Medical Wearable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
        7.6.4 Avation Medical Wearable Neuromodulation Device Product Offerings
        7.6.5 Avation Medical Recent Developments
    7.7 NeuroMetrix
        7.7.1 NeuroMetrix Company Information
        7.7.2 NeuroMetrix Introduction and Business Overview
        7.7.3 NeuroMetrix Wearable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
        7.7.4 NeuroMetrix Wearable Neuromodulation Device Product Offerings
        7.7.5 NeuroMetrix Recent Developments
    7.8 Softeq Development
        7.8.1 Softeq Development Company Information
        7.8.2 Softeq Development Introduction and Business Overview
        7.8.3 Softeq Development Wearable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
        7.8.4 Softeq Development Wearable Neuromodulation Device Product Offerings
        7.8.5 Softeq Development Recent Developments
    7.9 Cala Health, Inc.
        7.9.1 Cala Health, Inc. Company Information
        7.9.2 Cala Health, Inc. Introduction and Business Overview
        7.9.3 Cala Health, Inc. Wearable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
        7.9.4 Cala Health, Inc. Wearable Neuromodulation Device Product Offerings
        7.9.5 Cala Health, Inc. Recent Developments
    7.10 Neurotherapeutics Ltd
        7.10.1 Neurotherapeutics Ltd Company Information
        7.10.2 Neurotherapeutics Ltd Introduction and Business Overview
        7.10.3 Neurotherapeutics Ltd Wearable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
        7.10.4 Neurotherapeutics Ltd Wearable Neuromodulation Device Product Offerings
        7.10.5 Neurotherapeutics Ltd Recent Developments
    7.11 BlueWind Medical
        7.11.1 BlueWind Medical Company Information
        7.11.2 BlueWind Medical Introduction and Business Overview
        7.11.3 BlueWind Medical Wearable Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
        7.11.4 BlueWind Medical Wearable Neuromodulation Device Product Offerings
        7.11.5 BlueWind Medical Recent Developments

8 Industry Chain Analysis
    8.1 Wearable Neuromodulation Device Industrial Chain
    8.2 Wearable Neuromodulation Device Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Key Suppliers of Raw Materials
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customer Analysis)
    8.5 Sales Model and Sales Channelss
        8.5.1 Wearable Neuromodulation Device Sales Model
        8.5.2 Sales Channels
        8.5.3 Wearable Neuromodulation Device Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Wearable Neuromodulation Device Market Trends
 Table 2. Wearable Neuromodulation Device Market Drivers & Opportunities
 Table 3. Wearable Neuromodulation Device Market Challenges
 Table 4. Wearable Neuromodulation Device Market Restraints
 Table 5. Global Wearable Neuromodulation Device Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Wearable Neuromodulation Device Revenue Market Share by Company (2021–2026)
 Table 7. Global Wearable Neuromodulation Device Sales Volume by Company (K Units), 2021–2026
 Table 8. Global Wearable Neuromodulation Device Sales Volume Market Share by Company (2021–2026)
 Table 9. Global Market Wearable Neuromodulation Device Price by Company (US$/Unit), 2021–2026
 Table 10. Key Manufacturers Wearable Neuromodulation Device Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Wearable Neuromodulation Device Product Type
 Table 12. Key Manufacturers Start of Mass Production of Wearable Neuromodulation Device
 Table 13. Global Wearable Neuromodulation Device Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Wearable Neuromodulation Device revenue, 2025
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Wearable Neuromodulation Device Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Wearable Neuromodulation Device Sales Value by Type (US$ Million), 2021–2026
 Table 18. Global Wearable Neuromodulation Device Sales Value by Type (US$ Million), 2027–2032
 Table 19. Global Wearable Neuromodulation Device Sales Market Share in Value by Type (2021–2026)
 Table 20. Global Wearable Neuromodulation Device Sales Market Share in Value by Type (2027–2032)
 Table 21. Global Wearable Neuromodulation Device Sales Volume by Type: 2021 vs 2025 vs 2032 (K Units)
 Table 22. Global Wearable Neuromodulation Device Sales Volume by Type (K Units), 2021–2026
 Table 23. Global Wearable Neuromodulation Device Sales Volume by Type (K Units), 2027–2032
 Table 24. Global Wearable Neuromodulation Device Sales Market Share in Volume by Type (2021–2026)
 Table 25. Global Wearable Neuromodulation Device Sales Market Share in Volume by Type (2027–2032)
 Table 26. Global Wearable Neuromodulation Device Price by Type (US$/Unit), 2021–2026
 Table 27. Global Wearable Neuromodulation Device Price by Type (US$/Unit), 2027–2032
 Table 28. Global Wearable Neuromodulation Device Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 29. Global Wearable Neuromodulation Device Sales Value by Application (US$ Million), 2021–2026
 Table 30. Global Wearable Neuromodulation Device Sales Value by Application (US$ Million), 2027–2032
 Table 31. Global Wearable Neuromodulation Device Sales Market Share in Value by Application (2021–2026)
 Table 32. Global Wearable Neuromodulation Device Sales Market Share in Value by Application (2027–2032)
 Table 33. Global Wearable Neuromodulation Device Sales Volume by Application: 2021 vs 2025 vs 2032 (K Units)
 Table 34. Global Wearable Neuromodulation Device Sales Volume by Application (K Units), 2021–2026
 Table 35. Global Wearable Neuromodulation Device Sales Volume by Application (K Units), 2027–2032
 Table 36. Global Wearable Neuromodulation Device Sales Market Share in Volume by Application (2021–2026)
 Table 37. Global Wearable Neuromodulation Device Sales Market Share in Volume by Application (2027–2032)
 Table 38. Global Wearable Neuromodulation Device Price by Application (US$/Unit), 2021–2026
 Table 39. Global Wearable Neuromodulation Device Price by Application (US$/Unit), 2027–2032
 Table 40. Global Wearable Neuromodulation Device Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 41. Global Wearable Neuromodulation Device Sales Value by Region (US$ Million), 2021–2026
 Table 42. Global Wearable Neuromodulation Device Sales Value by Region (US$ Million), 2027–2032
 Table 43. Global Wearable Neuromodulation Device Sales Value by Region (%), 2021–2026
 Table 44. Global Wearable Neuromodulation Device Sales Value by Region (%), 2027–2032
 Table 45. Global Wearable Neuromodulation Device Sales Volume by Region (K Units): 2021 vs 2025 vs 2032
 Table 46. Global Wearable Neuromodulation Device Sales Volume by Region (K Units), 2021–2026
 Table 47. Global Wearable Neuromodulation Device Sales Volume by Region (K Units), 2027–2032
 Table 48. Global Wearable Neuromodulation Device Sales Volume by Region (%), 2021–2026
 Table 49. Global Wearable Neuromodulation Device Sales Volume by Region (%), 2027–2032
 Table 50. Global Wearable Neuromodulation Device Average Price by Region (US$/Unit), 2021–2026
 Table 51. Global Wearable Neuromodulation Device Average Price by Region (US$/Unit), 2027–2032
 Table 52. Key Countries/Regions Wearable Neuromodulation Device Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 53. Key Countries/Regions Wearable Neuromodulation Device Sales Value, (US$ Million), 2021–2026
 Table 54. Key Countries/Regions Wearable Neuromodulation Device Sales Value, (US$ Million), 2027–2032
 Table 55. Key Countries/Regions Wearable Neuromodulation Device Sales Volume, (K Units), 2021–2026
 Table 56. Key Countries/Regions Wearable Neuromodulation Device Sales Volume, (K Units), 2027–2032
 Table 57. Nexalin Company Information
 Table 58. Nexalin Introduction and Business Overview
 Table 59. Nexalin Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 60. Nexalin Wearable Neuromodulation Device Product Offerings
 Table 61. Nexalin Recent Developments
 Table 62. Cefaly Company Information
 Table 63. Cefaly Introduction and Business Overview
 Table 64. Cefaly Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 65. Cefaly Wearable Neuromodulation Device Product Offerings
 Table 66. Cefaly Recent Developments
 Table 67. ​Theranica Bio-Electronics Ltd. Company Information
 Table 68. ​Theranica Bio-Electronics Ltd. Introduction and Business Overview
 Table 69. ​Theranica Bio-Electronics Ltd. Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 70. ​Theranica Bio-Electronics Ltd. Wearable Neuromodulation Device Product Offerings
 Table 71. ​Theranica Bio-Electronics Ltd. Recent Developments
 Table 72. Neurolief Inc. Company Information
 Table 73. Neurolief Inc. Introduction and Business Overview
 Table 74. Neurolief Inc. Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 75. Neurolief Inc. Wearable Neuromodulation Device Product Offerings
 Table 76. Neurolief Inc. Recent Developments
 Table 77. eNeura Inc. Company Information
 Table 78. eNeura Inc. Introduction and Business Overview
 Table 79. eNeura Inc. Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 80. eNeura Inc. Wearable Neuromodulation Device Product Offerings
 Table 81. eNeura Inc. Recent Developments
 Table 82. Avation Medical Company Information
 Table 83. Avation Medical Introduction and Business Overview
 Table 84. Avation Medical Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 85. Avation Medical Wearable Neuromodulation Device Product Offerings
 Table 86. Avation Medical Recent Developments
 Table 87. NeuroMetrix Company Information
 Table 88. NeuroMetrix Introduction and Business Overview
 Table 89. NeuroMetrix Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 90. NeuroMetrix Wearable Neuromodulation Device Product Offerings
 Table 91. NeuroMetrix Recent Developments
 Table 92. Softeq Development Company Information
 Table 93. Softeq Development Introduction and Business Overview
 Table 94. Softeq Development Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 95. Softeq Development Wearable Neuromodulation Device Product Offerings
 Table 96. Softeq Development Recent Developments
 Table 97. Cala Health, Inc. Company Information
 Table 98. Cala Health, Inc. Introduction and Business Overview
 Table 99. Cala Health, Inc. Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 100. Cala Health, Inc. Wearable Neuromodulation Device Product Offerings
 Table 101. Cala Health, Inc. Recent Developments
 Table 102. Neurotherapeutics Ltd Company Information
 Table 103. Neurotherapeutics Ltd Introduction and Business Overview
 Table 104. Neurotherapeutics Ltd Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 105. Neurotherapeutics Ltd Wearable Neuromodulation Device Product Offerings
 Table 106. Neurotherapeutics Ltd Recent Developments
 Table 107. BlueWind Medical Company Information
 Table 108. BlueWind Medical Introduction and Business Overview
 Table 109. BlueWind Medical Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 110. BlueWind Medical Wearable Neuromodulation Device Product Offerings
 Table 111. BlueWind Medical Recent Developments
 Table 112. Key Raw Materials Lists
 Table 113. Key Suppliers of Raw Materials Lists
 Table 114. Wearable Neuromodulation Device Downstream Customers
 Table 115. Wearable Neuromodulation Device Distributors List
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources


List of Figures
 Figure 1. Wearable Neuromodulation Device Product Picture
 Figure 2. Global Wearable Neuromodulation Device Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Wearable Neuromodulation Device Sales Value (US$ Million), 2021–2032
 Figure 4. Global Wearable Neuromodulation Device Sales Volume (K Units), 2021–2032
 Figure 5. Global Wearable Neuromodulation Device Sales Price (US$/Unit), 2021–2032
 Figure 6. Wearable Neuromodulation Device Report Years Considered
 Figure 7. Global Wearable Neuromodulation Device Players Revenue Ranking (US$ Million), 2025
 Figure 8. Global Wearable Neuromodulation Device Sales Volume Ranking of Players (K Units), 2025
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Wearable Neuromodulation Device Revenue in 2025
 Figure 10. Wearable Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 11. Head Mounted Picture
 Figure 12. Hand-worn Picture
 Figure 13. Leg-worn Picture
 Figure 14. Foot-worn Picture
 Figure 15. Global Wearable Neuromodulation Device Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Wearable Neuromodulation Device Sales Value Market Share by Type, 2025 & 2032
 Figure 17. Global Wearable Neuromodulation Device Sales Volume by Type (K Units), 2021 vs 2025 vs 2032
 Figure 18. Global Wearable Neuromodulation Device Sales Volume Market Share by Type, 2025 & 2032
 Figure 19. Global Wearable Neuromodulation Device Price by Type (US$/Unit), 2021–2032
 Figure 20. Product Picture of Hospital
 Figure 21. Product Picture of Clinic
 Figure 22. Product Picture of Residential
 Figure 23. Product Picture of Nursing Home
 Figure 24. Product Picture of Others
 Figure 25. Global Wearable Neuromodulation Device Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 26. Global Wearable Neuromodulation Device Sales Value Market Share by Application, 2025 & 2032
 Figure 27. Global Wearable Neuromodulation Device Sales Volume by Application (K Units), 2021 vs 2025 vs 2032
 Figure 28. Global Wearable Neuromodulation Device Sales Volume Market Share by Application, 2025 & 2032
 Figure 29. Global Wearable Neuromodulation Device Price by Application (US$/Unit), 2021–2032
 Figure 30. North America Wearable Neuromodulation Device Sales Value (US$ Million), 2021–2032
 Figure 31. North America Wearable Neuromodulation Device Sales Value by Country (%), 2025 vs 2032
 Figure 32. Europe Wearable Neuromodulation Device Sales Value (US$ Million), 2021–2032
 Figure 33. Europe Wearable Neuromodulation Device Sales Value by Country (%), 2025 vs 2032
 Figure 34. Asia Pacific Wearable Neuromodulation Device Sales Value (US$ Million), 2021–2032
 Figure 35. Asia Pacific Wearable Neuromodulation Device Sales Value by Region (%), 2025 vs 2032
 Figure 36. South America Wearable Neuromodulation Device Sales Value (US$ Million), 2021–2032
 Figure 37. South America Wearable Neuromodulation Device Sales Value by Country (%), 2025 vs 2032
 Figure 38. Middle East & Africa Wearable Neuromodulation Device Sales Value (US$ Million), 2021–2032
 Figure 39. Middle East & Africa Wearable Neuromodulation Device Sales Value by Country (%), 2025 vs 2032
 Figure 40. Key Countries/Regions Wearable Neuromodulation Device Sales Value (%), 2021–2032
 Figure 41. Key Countries/Regions Wearable Neuromodulation Device Sales Volume (%), 2021–2032
 Figure 42. United States Wearable Neuromodulation Device Sales Value (US$ Million), 2021–2032
 Figure 43. United States Wearable Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
 Figure 44. United States Wearable Neuromodulation Device Sales Value by Application (%), 2025 vs 2032
 Figure 45. Europe Wearable Neuromodulation Device Sales Value (US$ Million), 2021–2032
 Figure 46. Europe Wearable Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
 Figure 47. Europe Wearable Neuromodulation Device Sales Value by Application (%), 2025 vs 2032
 Figure 48. China Wearable Neuromodulation Device Sales Value (US$ Million), 2021–2032
 Figure 49. China Wearable Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
 Figure 50. China Wearable Neuromodulation Device Sales Value by Application (%), 2025 vs 2032
 Figure 51. Japan Wearable Neuromodulation Device Sales Value (US$ Million), 2021–2032
 Figure 52. Japan Wearable Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
 Figure 53. Japan Wearable Neuromodulation Device Sales Value by Application (%), 2025 vs 2032
 Figure 54. South Korea Wearable Neuromodulation Device Sales Value (US$ Million), 2021–2032
 Figure 55. South Korea Wearable Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
 Figure 56. South Korea Wearable Neuromodulation Device Sales Value by Application (%), 2025 vs 2032
 Figure 57. Southeast Asia Wearable Neuromodulation Device Sales Value (US$ Million), 2021–2032
 Figure 58. Southeast Asia Wearable Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
 Figure 59. Southeast Asia Wearable Neuromodulation Device Sales Value by Application (%), 2025 vs 2032
 Figure 60. India Wearable Neuromodulation Device Sales Value (US$ Million), 2021–2032
 Figure 61. India Wearable Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
 Figure 62. India Wearable Neuromodulation Device Sales Value by Application (%), 2025 vs 2032
 Figure 63. Wearable Neuromodulation Device Industrial Chain
 Figure 64. Wearable Neuromodulation Device Manufacturing Cost Structure
 Figure 65. Channels of Distribution (Direct Sales, and Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed